Home Daily Stock Opinions and Ratings Aptose Biosciences (APS-T)

Trending stocks today

BMO MSCI USA High Quality ETF MEG Energy Corp Athabasca Oil Sands Corp Arc Resources Ltd Royalty Pharma plc Mercury General Corp SABESP iShares 20+ Year Treasury Bond ETF Imperial Oil CASH Cleveland-Cliffs Inc. American Express CME Group Inc Expedia Mastercard Inc. Netflix Inc. Global Ship Lease Inc Equinor ASA Copa Holdings

Aptose Biosciences (APS-T)

NEW AI Investor Insights
9 watching

TSE:APS

5.22
0.43 (8.98%) 1d
Mar 13, 2025, 6:38 pm
0
PARTIAL BUY

Aptose Biosciences(APS-T)

Jul 05, 2019
Don't get scared of parabolic moves. The chart looks very good. It has shot up in the last 6 weeks. Its next move could be just under $6 pretty quickly. Relative strength vs. the S&P looks very good. However, expect volatility. Own a small holding.
Hap (Robert) Sneddon FCSI
Unknown
Unlock Rating
$3.930

Stock price when the opinion was issued

biotechnology pharmaceutical
RISKY

Aptose Biosciences(APS-T)

Apr 21, 2014

An old story, but re-invigorated by an impressive management team. Speculative. Recent sell off in biotech has not helped them.

Fabrice Taylor
Unknown
Unlock Rating
$0.540

Stock price when the opinion was issued

biotechnology pharmaceutical
SELL

Aptose Biosciences(APS-T)

Nov 17, 2005
At this point, it's a lottery ticket, so for a conservative, fundamental investor, he would call it a sell. Their therapy for pancreatic cancer hasn't been shown to be effective. Be very, very cautious over the next couple of months because it's an orphan stock and you are going into tax loss selling.
Peter Hodson
Unknown
Unlock Rating
$0.285

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Aptose Biosciences(APS-T)

Sep 29, 2005
A very interesting company. Has always been a bit of a disappointment. Once they get their FDA approval then the stock should go.
Robert Floyd
Owned
Unlock Rating
$0.670

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Aptose Biosciences(APS-T)

Jun 28, 2004
One of the more undervalued of the biotech's. Have a number of interesting products that are being developed. Has been disappointed in the stock performance. Need some news that will push the valuation.
Robert Floyd
Owned
Unlock Rating
$0.840

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Aptose Biosciences(APS-T)

Jun 01, 2004
Have done well getting approvals on their products but the stock hasn't done very much. Would like to get rid of his holdings, but not at this price.
Robert Floyd
Owned
Unlock Rating
$0.860

Stock price when the opinion was issued

biotechnology pharmaceutical
WEAK BUY

Aptose Biosciences(APS-T)

Apr 19, 2004
Not their favorite biotech. Cancer Institute has given them a lot of money for phase two studies. Possibly have a very elegant solution. Expect there will be a lot of news as phase two trials proceed. Volatile. Early stages so only buy a little.
Hugh McCauley
Owned
Unlock Rating
$1.060

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Aptose Biosciences(APS-T)

Dec 09, 2003
Highly speculative. A very high number of shares outstanding. Trading below its 50/200 day moving average. Struggling to hold on to its current level. Have had 10 quarters of losses.
Lou Schizas
Unknown
Unlock Rating
$1.040

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Aptose Biosciences(APS-T)

Dec 08, 2003
A very interesting stock at this price. Good cancer drugs. Still awaiting trial completions in the US. Also have new products.
Robert Floyd
Owned
Unlock Rating
$1.070

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Aptose Biosciences(APS-T)

Sep 22, 2003
Getting a lot of patent approvals. A growth story in the making. Have an extensive profile. Have recently flushed out their balance sheets with an issue. A very interesting story, but can be somewhat volatile.
Robert Floyd
Owned
Unlock Rating
$1.290

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Aptose Biosciences(APS-T)

Aug 20, 2003
High-risk company.You should own five or six in this sector in order to spread the risks.
Mark Jackson, CFA
No
Unlock Rating
$1.230

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY ON WEAKNESS

Aptose Biosciences(APS-T)

Jul 21, 2003
Charts indicate a risky stock. If you want to buy, pick a point 10/15% below its recent low.
Larry Berman CFA, CMT, CTA
No
Unlock Rating
$1.180

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Aptose Biosciences(APS-T)

Jul 04, 2003
Just did a financing to extend development on new products. Sees further improvement.
Robert Floyd
Owned
Unlock Rating
$1.250

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Aptose Biosciences(APS-T)

Jun 24, 2003
Has never generated any degree of profitability. Speculative.
Jonathen Wellum, B. Comm, B. Sc
No
Unlock Rating
$1.230

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Aptose Biosciences(APS-T)

May 14, 2003
Received patent approval on one of their processes. New drugs for cancer are being tested in Mexico and USA. You have to keep an eye on this one.
John Sinkins, CFA
Unknown
Unlock Rating
$1.410

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 15 of 44 entries
Next PageNext Page

Aptose Biosciences(APS-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Aptose Biosciences is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Aptose Biosciences(APS-T) Frequently Asked Questions

What is Aptose Biosciences stock symbol?

Aptose Biosciences is a Canadian stock, trading under the symbol APS-T on the Toronto Stock Exchange (APS-CT). It is usually referred to as TSX:APS or APS-T

Is Aptose Biosciences a buy or a sell?

In the last year, there was no coverage of Aptose Biosciences published on Stockchase.

Is Aptose Biosciences a good investment or a top pick?

Aptose Biosciences was recommended as a Top Pick by on . Read the latest stock experts ratings for Aptose Biosciences.

Why is Aptose Biosciences stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Aptose Biosciences worth watching?

0 stock analysts on Stockchase covered Aptose Biosciences In the last year. It is a trending stock that is worth watching.

What is Aptose Biosciences stock price?

On 2025-03-13, Aptose Biosciences (APS-T) stock closed at a price of $5.22.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

OMC-NOmnicom Group
Omnicom Group
$80.93
1.45 (1.76%)
BIPC-TBrookfield Infrastructure Partners
Brookfield Infrastructure Partners
$49.75
0.30 (0.60%)
AAPL-QApple Inc
Apple Inc
$213.11
3.43 (1.58%)
ET-TEvertz Technologies Ltd.
Evertz Technologies Ltd.
$11.02
0.05 (0.45%)
AZN-NAstrazeneca P L C
Astrazeneca P L C
$77.47
0.96 (1.22%)
Advertising

Today's Top Picks

CPA-NCopa Holdings
Copa Holdings
$93.04
1.04 (1.11%)
EQNR-NEquinor ASA
Equinor ASA
$24.14
0.36 (1.47%)
GSL-NGlobal Ship Lease Inc
Global Ship Lease Inc
$23.08
0.10 (0.43%)
NFLX-QNetflix Inc.
Netflix Inc.
$912.90
22.73 (2.43%)
MA-NMastercard Inc.
Mastercard Inc.
$528.02
8.19 (1.53%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

AMD-QAdvanced Micro Devices
Advanced Micro Devices
$100.81
2.70 (2.61%)
BCE-TBCE Inc.
BCE Inc.
$33.76
-0.41 (-1.22%)
SHOP-TShopify Inc.
Shopify Inc.
$135.60
4.88 (3.47%)
ZWB-TBMO Covered Call Canadian Banks ETF
BMO Covered Call Canadian Banks ETF
$18.74
0.30 (1.58%)
CNQ-TCanadian Natural Rsrcs
Canadian Natural Rsrcs
$42.23
0.84 (1.95%)

Most Recent Experts

Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Richards

Keith Richards

ValueTrend Wealth Management

Stockchase

Stockchase Insights

5i Research

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.